Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study

Eur J Cancer. 2022 Nov 12;179:15-24. doi: 10.1016/j.ejca.2022.10.029. Online ahead of print.

NO ABSTRACT

PMID:36470023 | DOI:10.1016/j.ejca.2022.10.029

Full Text Link: Read More

Generated by Feedzy